{"lastClose": 48.0, "len": 1654, "date": "2022-11-29", "alpha_1": -0.5226017137596096, "beta_1": 2.1155295216935692, "drawup_1": 0.8628213515603638, "natr_1": 14.19085257234629, "sup_1": -0.11701387829250749, "res_1": 0.23784719573126903, "bullPattern_1": [], "bearPattern_1": ["SHORTLINE"], "rsi_1": 44.93861803744022, "adx_1": 9.29663410099018, "drawdown_1": -0.6999064141047084, "alpha_3mo": -0.673844752902863, "beta_3mo": 1.5111602387226666, "drawup_3mo": 0.23857690363008022, "natr_3mo": 14.19085257234629, "sup_3mo": -0.0174305968814427, "res_3mo": 0.09013888570997446, "bullPattern_3mo": [], "bearPattern_3mo": ["SPINNINGTOP"], "rsi_3mo": 45.69983501810427, "adx_3mo": 17.197390391445737, "drawdown_3mo": -0.30008750775121096, "Industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances", "Sector": "Health Care", "Market Cap": 3783128595, "Name": "Intellia Therapeutics Inc.", "IPO Year": 2016.0, "Country": "United States", "alpha_5": 0.4558668296168744, "beta_5": 1.8006297961551716, "drawup_5": 17.726695618361344, "sharpe_5": 0.606352177169104, "natr_5": 14.19085257234629, "sup_5": -1.0690972010294597, "res_5": 1.077222188313802, "bullPattern_5": [], "bearPattern_5": ["SHORTLINE"], "rsi_5": 43.5056749295628, "adx_5": 11.356526602561049, "drawdown_5": -0.7822717391998621, "alpha%_1": 0.13662359558631676, "beta%_1": 0.9841058135906292, "drawup%_1": 0.8902398156938501, "natr%_1": 0.9999100198038703, "drawdown%_1": 0.07918750498274585, "alpha%_3mo": 0.12674261685850585, "beta%_3mo": 0.8494083363553129, "drawup%_3mo": 0.4379593396036057, "natr%_3mo": 0.9998790997455185, "drawdown%_3mo": 0.17069107125658256, "alpha%_5": 0.9961005794601607, "beta%_5": 0.9927762207246575, "drawup%_5": 0.999999999999998, "sharpe%_5": 0.7672728005424587, "natr%_5": 0.9999999998147316, "drawdown%_5": 0.17654551672205115}